Cardium Announces Commercial Development of Excellagen(TM) a Customized Collagen-Based Topical Gel for Initial Use as an Adjunct to Surgical Debridement in Patients With Diabetic Foot Ulcers
Important Clinical Findings Provide New Therapeutic Insights into Healing Potential of Cardium's Matrix Technology Platform
* Press Release * Source: Cardium Therapeutics * On 9:04 am EDT, Wednesday October 14, 2009
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.